HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – HC Wainwright upped their Q4 2025 EPS estimates for shares of HIVE Blockchain Technologies in a research note issued on Tuesday, December 3rd. HC Wainwright analyst M. Colonnese now expects that the company will earn ($0.08) per share for the quarter, up from their prior estimate of ($0.10). HC Wainwright has a “Strong-Buy” rating on the stock. HC Wainwright also issued estimates for HIVE Blockchain Technologies’ Q4 2026 earnings at $0.10 EPS and FY2026 earnings at $0.13 EPS.
A number of other analysts have also issued reports on HIV. Cantor Fitzgerald upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a report on Tuesday, October 29th. Northland Capmk raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Thursday, September 19th.
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
Featured Stories
- Five stocks we like better than HIVE Blockchain Technologies
- How to Use Stock Screeners to Find Stocks
- Trinity Capital CEO on Leading Private Credit’s High-Yield Growth
- How to Capture the Benefits of Dividend Increases
- Lululemon Surges On Q3 Report: Analysts Step in To Support Market
- How to Buy Cheap Stocks Step by Step
- 10 Safe Investments with High Returns
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
